Nilsson P

JSON
CSV
XLSX
TXT
Family name Nilsson
Given name Peter
Initials P
ORCID

ORCID 0000-0002-4657-8532
Affiliations Division of Affinity Proteomics Department of Protein Science KTH Royal Institute of Technology SciLifeLab Stockholm Sweden.

12 publications

PubMed DOI Crossref
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19.
Jernbom AF, Skoglund L, Pin E, ..., Månberg A, Nilsson P
Nat Commun 15 (1) 8941 [2024-10-17; online 2024-10-17]
DOI Crossref
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
Marking U, Havervall S, Norin NG, ..., Klingström J, Thålin C
Nat Commun 14 (1) - [2023-03-22; online 2023-03-22]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Type: Journal article
PubMed DOI Crossref
Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination.
Blixt L, Gao Y, Wullimann D, ..., Hansson L, Österborg A
Blood 140 (22) 2403-2407 [2022-12-01; online 2022-09-24]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Type: Journal article
PubMed DOI Crossref
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.
Marking U, Havervall S, Greilert-Norin N, ..., Åberg M, Thålin C
Vaccines 10 (3) 359 [2022-02-24; online 2022-02-24]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Havervall S, Jernbom Falk A, Klingström J, ..., Nilsson P, Thålin C
PLoS One 17 (1) e0262169 [2022-01-12; online 2022-01-12]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
PubMed DOI Crossref
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
Healy K, Pin E, Chen P, ..., Aleman S, Sällberg Chen M
Med (N Y) - (-) - [2022-01-00; online 2022-01-00]
Category: Biochemistry Category: Health Category: Vaccines Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Vaccine Type: Journal article
DOI Crossref
Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time
Havervall S, Marking U, Greilert‐Norin N, ..., Åberg M, Thålin C
Clin Transl Immunol 11 (4) - [2022-01-00; online 2022-04-18]
Category: Biochemistry Category: Health Category: Vaccines Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S, Ng H, Jernbom Falk A, ..., Hober S, Thålin C
J Intern Med 291 (1) 72-80 [2022-01-00; online 2021-09-27]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Research Area: Viral sequence evolution
PubMed DOI Crossref
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients.
Blixt L, Bogdanovic G, Buggert M, ..., Hansson L, Österborg A
Leukemia - (-) - [2021-09-25; online 2021-09-25]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: High-throughput and high-content serology Type: Journal article
PubMed DOI Crossref
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
Asplund Högelin K, Ruffin N, Pin E, ..., Piehl F, Al Nimer F
iScience 24 (9) 103078 [2021-09-00; online 2021-09-00]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: High-throughput and high-content serology Research Area: Vaccine Type: Journal article
PubMed DOI Crossref
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.
Hober S, Hellström C, Olofsson J, ..., Hedhammar M, Nilsson P
Clin Transl Immunol 10 (7) e1312 [2021-07-19; online 2021-07-19]
Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
PubMed DOI Crossref
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.
Rudberg AS, Havervall S, Månberg A, ..., Hober S, Thålin C
Nat Commun 11 (1) 5064 [2020-10-08; online 2020-10-08]
Category: Health Category: Serology Funder: H2020 Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article
SciLifeLab Data Centre
Publications 9.5.1